跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APX-PARACETAMOL/CODEINE paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
APX-PARACETAMOL/CODEINE paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack
Approved
STANDARD
APX-PARACETAMOL/CODEINE paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
4ad5e015cde66e65
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
4ad5e015cde66e65
Product Name
APX-PARACETAMOL/CODEINE paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack
Artg Id
338093
Artg Name
APX-PARACETAMOL/CODEINE paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2020-06-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/73ff24e00989dcdc51bf10201817a231.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1eeede22f92e3f22d071cf663b16346f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
4ad5e015cde66e65
Type
Standard
Back to TGA Approvals